Your browser doesn't support javascript.
loading
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.
Sclafani, F; Chau, I; Cunningham, D; Peckitt, C; Lampis, A; Hahne, J C; Braconi, C; Tabernero, J; Glimelius, B; Cervantes, A; Begum, R; Gonzalez De Castro, D; Hulkki Wilson, S; Eltahir, Z; Wotherspoon, A; Tait, D; Brown, G; Oates, J; Valeri, N.
Afiliação
  • Sclafani F; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Chau I; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Cunningham D; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Peckitt C; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Lampis A; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton.
  • Hahne JC; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton.
  • Braconi C; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey; Division of Cancer Therapeutics, The Institute of Cancer Research, London and Sutton, UK.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Glimelius B; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden.
  • Cervantes A; Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Begum R; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Gonzalez De Castro D; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Hulkki Wilson S; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Eltahir Z; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Wotherspoon A; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Tait D; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Brown G; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Oates J; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Valeri N; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton. Electronic address: nicola.valeri@icr.ac.uk.
Ann Oncol ; 26(9): 1936-1941, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26162609
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Proteínas Proto-Oncogênicas p21(ras) / Terapia Neoadjuvante / MicroRNAs Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Proteínas Proto-Oncogênicas p21(ras) / Terapia Neoadjuvante / MicroRNAs Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article